We answer questions every day for stroke and TBI patients worldwide.
A stroke survivor who suffered a stroke in December 2025 shares her initial observations immediately following Perispinal Etanercept (PSE) treatment
A patient who traveled from Vancouver, Canada, shares his experience following a stroke suffered at the end of 2020. The
In this feature by 60 Minutes Australia, correspondents examine the application of Perispinal Etanercept (PSE) at the Institute of Neurological
A stroke survivor who traveled from Zimbabwe reports changes in speech fluency, sentence formation, taste return, hand mobility, leg balance,
Improvement in speech, post-stroke pain, left neglect, sensation, and spasticity after PSE treatment by Dr. Tobinick, 1.5 years after stroke.
Patient’s family and occupational therapist observe improvements in cognition, vision, post-stroke pain, walking, fine motor function, speech, fatigue, and swallowing
Patient from Grenada exhibits rapid improvement in sensation, hand function/writing, motor function/strength, walking, speech, and taste following PSE treatment by
Immediate improvement in post-stroke pain, balance, vision, hearing, speech, and swallowing following PSE treatment by Dr. Tobinick, 12 years after
Patient from London notes multiple improvements in post-stroke pain, sensation, walking, balance, brain fog, and speech after PSE treatment by
“This has changed our lives big time.” Improvements in post-stroke pain, post-stroke fatigue, balance, cognition, speech, swallowing, and spasticity. Treatment
Perispinal etanercept is a method of targeting detrimental neuroinflammation using etanercept, a special anti-inflammatory drug, delivered utilizing a novel, non-invasive injection method.
Perispinal etanercept is NOT experimental. Perispinal etanercept has been used to treat more than 5,000 chronic stroke patients since 2010 at the Institute of Neurological Recovery.
No, it is not too late. Neuroinflammation can last for years, or even decades, after brain injury. Life-changing neurological improvements following perispinal etanercept treatment performed weeks, months, years, or even decades after stroke or brain injury are not uncommon.
Referrals are not required. The Institute of Neurological Recovery has received, and welcomes, referrals from neurologists, speech pathologists, physical therapists, occupational therapists, primary care physicians, online stroke groups, and, of course, patients and their family members.
